ID   GT39
AC   CVCL_C8NI
SY   GT-39
DR   BTO; BTO_0006491
DR   Wikidata; Q123031378
RX   PubMed=9600119;
RX   PubMed=11543663;
CC   Population: Japanese.
CC   Doubling time: ~22 hours (PubMed=9600119).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=9600119; DOI=10.1111/j.1349-7006.1998.tb00557.x; PMCID=PMC5921807;
RA   Tajima M., Komuro M., Okinaga K.;
RT   "Establishment of Epstein-Barr virus-positive human gastric epithelial
RT   cell lines.";
RL   Jpn. J. Cancer Res. 89:262-268(1998).
//
RX   PubMed=11543663; DOI=10.1006/viro.2001.1071;
RA   Fukuda M., Ikuta K., Yanagihara K., Tajima M., Kuratsune H.,
RA   Kurata T., Sairenji T.;
RT   "Effect of transforming growth factor-beta1 on the cell growth and
RT   Epstein-Barr virus reactivation in EBV-infected epithelial cell
RT   lines.";
RL   Virology 288:109-118(2001).
//